Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. In turn, cannabis advocates have struggled to properly educate the public with the limited amount of scientific evidence available. states pass relevant legislation and educating doctors about the power of cannabis medicine.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Project CBD

MAY 3, 2023

She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Remember, the pharmaceutical model is “this medicine addresses this specific target.”

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. In Western medicine, the psychedelic revolution is coming at the perfect moment as the country grapples with a post-COVID world.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Cannabis Law Report

JULY 7, 2021

Tilray is embarking on a push to educate more German doctors about the benefits of prescribing medical cannabis, as the weed giant seeks to cement its dominance in the highly-profitable European medical market. The Canadian weed giant marked a milestone in Germany this week, harvesting the country’s first medical cannabis crop.

Clinical Trials 105

Clinical Trials Education Data Pharmaceutical 105

FloridaMarijuana.net

AUGUST 16, 2018

Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. The clinical trials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

NOVEMBER 19, 2021

MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. We are committed to continuing to lead the field of psychedelic medicine with integrity and ethics at the core. Why work for MAPS Public Benefit Corporation (MAPS PBC)? Just posted.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

JANUARY 26, 2022

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. No drug is without risks, so clinical trials have included careful investigation of possible adverse effects.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

The Cannigma

AUGUST 31, 2021

The poll was carried out by People Science , a tech-enabled science company that describes its mission as bringing together “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines.”. We have a ways to go,” Tan said. The survey also found that 89.5%

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

JANUARY 19, 2022

Congressman Moran introduced the AUTISM Educators Act in 2012, which funded partnerships between public schools and higher education and non-profit organizations to promote teaching skills for educators working with high functioning autism students. The Company also operates an infrastructure business based in India.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Cannabis Law Report

APRIL 8, 2019

Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Australia’s medicinal cannabis industry continues to flourish. Chapter 2 of the NDA.

Medicine 71

Medicine Research and Development Business Cannabis 71

The Cannigma

OCTOBER 14, 2022

Established in 2016 by a citizen’s initiative, patients can purchase cannabis-based medicines like Sativex to treat a number of approved conditions including multiple sclerosis, spine injuries, and neuropathic pain. San Marino medical marijuana program. This medication is provided at no cost to residents of the country.

Law 56

Law Clinical Trials Research and Development Recreational 56

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult. Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. 124’—the use and application of medicines manufactured from “marijuana” to any person are currently prohibited.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

MAY 28, 2022

The firm represents clients around the world in major industries including energy and natural resources; financial services and capital markets; food and agribusiness; healthcare, life sciences and education; real estate, development and construction; and technology, manufacturing and transportation. How did this come to fruition?

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

Cannabis Law Report

OCTOBER 2, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. MAPS is pushing forward research on a number of psychedelics with potential in medicine. Fund associated research, administered by MAPS PBC, with additional capital.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

AUGUST 21, 2019

The National Institute for Health and Care Excellence (NICE) reviewed evidence for the benefits and costs of cannabis-based medicinal products and drew up guidance for health professionals and the public. It also said the children’s experiences on medicinal cannabis in the should be taken into account as evidence of how well the drug works.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

JULY 27, 2021

Research opportunities such as the ORR expand the existing scientific knowledge base to better inform clinical decision making, and also dispels the stigma surrounding medicinal cannabis use.”. plan to conduct a controlled clinical trial to further understand the effects of CBD in epilepsy treatment.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. .

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Cannabis Law Report

NOVEMBER 19, 2021

MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. We are committed to continuing to lead the field of psychedelic medicine with integrity and ethics at the core. Why work for MAPS Public Benefit Corporation (MAPS PBC)?

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

APRIL 21, 2022

MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. We are committed to continuing to lead the field of psychedelic medicine with integrity and ethics at the core. Education – Bachelor’s degree (or equivalent professional experience).

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

CannaTech

SEPTEMBER 16, 2018

While Canada’s medicinal cannabis framework has gone through many iterations, Canada has led the way in showing to the world how to think about cannabis. What began as a legal medicine more than 15 years is now being legalized for adult recreational use. The Need for Cannabis Education Tailored to Patient and Doctor.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

FloridaMarijuana.net

OCTOBER 9, 2018

The cannabis plant has been used medicinally for a multitude of health issues, specifically chronic pain. As the use of medicinal cannabis increases throughout Florida and the United States, patients are discovering the relief that the plant offers. Science now understands that the whole cannabis plant offers medicinal properties.

Terpenes 100

Terpenes Chronic Pain Strains Clinical Trials 100

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. National Library of Medicine website. Accessed October 17, 2022. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Peninsula Alternative Health

MAY 15, 2019

The challenging part is that every individual strain is a different medicine and every individual cancer is a different disease. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. Naturally, cells in our bodies are not mobile but cancer cells are.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JUNE 4, 2021

The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. Clinical trial information: NCT03276572 ( [link] ). The full presentation is available at: [link]. Abstract Number: 5015.

Data 100

Data Research and Development Clinical Trials Therapy 100

FloridaMarijuana.net

JUNE 13, 2018

The American Cancer Society reported that studies have consistently shown that during clinical trials patients who used marijuana extracts needed less pain medicine and opioids. Another variety Rick Simpson Oil (RSO) was designed by a cancer patient and has more of a THC concentration.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

AUGUST 25, 2022

In addition to the clinical research program to make MDMA into an FDA-approved medicine, MAPS was founded to create sensible and compassionate alternatives to the War on Drugs. MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD.

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52

SpeedWeed

JULY 6, 2021

The US Food and Drug Administration is also currently sponsoring clinical trials that could lead to the federal legalization of psilocybin- and MDMA -assisted therapy within the next two years. The US market for medicinal psychedelics is predicted to grow to $6.85 View original article.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JANUARY 12, 2022

Through this collaboration, the NPA and Maya will offer both the education and the technology infrastructure needed to make this possible, ensuring accessibility and safety to all communities. “We Maya envisions a future where everyone has the opportunity to benefit from safe and accessible psychedelic medicine.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

FloridaMarijuana.net

AUGUST 9, 2018

The University of Maryland School of Medicine (UMSOM) published a paper detailing the inadequacies of current research. CBD is also an excellent option when integrating cannabis medicine into a healthcare routine. CBD (cannabidiol) is the non-psychoactive ingredient in cannabis. Relieve pain, inflammation and nausea.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

Puff Puff Post

SEPTEMBER 16, 2019

The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool. .

Programs 108

Programs Research and Development Education Treatment 108